great, here’s the brainiac , invariably comes out to condescend, seems to be some sort of company mouthpiece or lackey.
——you know more than the nephrologist who wrote this article for kdigo do you?
—//— saw your weak attempts to argue with another poster about rituximab and you came off 2nd best.
******this is marketing 101. Where is the drug positioned??. you seriously think it will usurp the other drugs already in use? Bonkers.
no need to concern yourself with my financial acumen, I’m loaded anyway thsnks to a seriously generous inheritance.
great, here’s the brainiac , invariably comes out to condescend,...
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.020(4.60%) |
Mkt cap ! $228.5M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 41.0¢ | $731.5K | 1.748M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 269178 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 14070 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |